Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes [1]

Diabetes Care

Volumn 22, Issue 12, 1999, Pages 2083-2084

  Oranje, Wilma A ^a   Rondas Colbers, Gabrielle J W M ^a   Swennen, Geertje N M ^a   Jansen, Hans ^b   Wolffenbuttel, Bruce H R ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT ACTIVITY; GLUCOSE HOMEOSTASIS; HUMAN; LETTER; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0033360979     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.12.2083     Document Type: Letter

References (12)

1. Giugliano D, Ceriello A: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
2. U.K. Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
3. Naito C, Kawamura M, Yamamoto Y: Lipid peroxides as the initiating factor of atherosclerosis. Ann N Y Acad Sci 676:27-45, 1993
4. Esterbauer H, Striegl G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6:67-75, 1989
5. Jansen H, Ghanem H, Kuypers JHSAM, Birkenhager JC: Autoantibodies against malondialdehyde-modined LDL are elevated in subjects with an LDL subclass pattern B. Atherosclerosis 115:255-262, 1995
6. Oranje WA, Rondas-Colbers GJWM, Swennen GNM, Wolffenbuttel BHR: Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease? Neth J Med 53:61-68, 1998
7. Yoshida H, Ishikawa T, Nakamura H: Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 17:1438-1446, 1997
8. Katoh K: Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus. Diabetes Res Clin Pract 18:89-98, 1992
9. Rifici VA, Schneider SH, Khachadurian AK: Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I. Atherosclerosis 107:99-108, 1994
10. Van Gaal L, Vertommen J, de Leeuw I: The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects. Atherosclerosis 137:S39-S44, 1998
11. O'Brien R, Luo M: The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro. Metabolism 46:22-25, 1997
12. Leinonen JS, Rantalaiho V, Solakivi T, Koivula T, Wirta O, Pasternack A, Alho H, Lehtimaki T: Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients. Clin Chim Acta 275:163-174, 1998